NCT04579523
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Multiple Myeloma
Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.
1,661 public trials
322 recruiting studies
Multiple Myeloma trial results
NCT07624513
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Not Yet Recruiting
Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging
NCT07624760
- Conditions
- AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +23 more
- Locations
-
- University Hospital Zurich Zurich, Canton of Zurich, Switzerland
Not Yet Recruiting
A Study of the Combination of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Participants With Multiple Myeloma and Moderate Hepatic Impairment
NCT07609706
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified
Not Yet Recruiting
Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma
NCT05976555
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified
Not Yet Recruiting
Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma
NCT07285239
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified
Not Yet Recruiting
Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma
NCT07569757
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- The First Affiliated Hospital of Bengbu Medical University Bengbu, Anhui, China
- The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
- Beijing Chao-Yang Hospital,Capital Medical University Beijing, Beijing Municipality, China
- Beijing Jishuitan Hospital,Capital Medical University Beijing, Beijing Municipality, China
Not Yet Recruiting
Emapalumab Prophylaxis of Bispecific T-Cell Engagers (BiTEs) Associated CRS and ICANS
NCT07567014
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- NYU Langone Health Perlmutter Cancer Center - Sunset Park Brooklyn, New York, United States
- NYU Langone Health Perlmutter Cancer Center - Manhattan Manhattan, New York, United States
- NYU Langone Health - Long Island Mineola, New York, United States
Not Yet Recruiting
BCMA Bispecific Antibody Therapy for Post-BCMA CAR T-Cell Therapy Relapse (RECLAIM)
NCT07009899
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States
NCT07542418
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified